臨床試驗

MagDI Canada Study

NCT：NCT06467955 · ACTIVE_NOT_RECRUITING

NCT IDNCT06467955

狀態ACTIVE_NOT_RECRUITING

開始日期2024-05-10

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-06-21

Last updated2026-05-20

簡要摘要

The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。